The Gross Margin of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM.NS) is 55.14%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-03-31 | 55.14% |
2023-03-31 | 56.77% |
2022-03-31 | 59.89% |
2021-03-31 | 57.02% |
2020-03-31 | 64.56% |
2019-03-31 | 56.33% |
2018-03-31 | 51.67% |
2017-03-31 | 58.54% |
2016-03-31 | 58.97% |
2015-03-31 | 50.29% |